Skip to main content
. Author manuscript; available in PMC: 2021 Jan 13.
Published in final edited form as: Lung Cancer. 2016 Sep 28;101:104–110. doi: 10.1016/j.lungcan.2016.09.015

Figure 2.

Figure 2

Mesothelin expression based on histology. Any level of mesothelin expression was seen in a significantly larger proportion of thymic carcinoma (n=27, 79%; middle column) than thymoma (n=3, 10%; left column) (P<0.0001). Mesothelin expression was absent in thymic neuroendocrine tumors (right column). Tumors showing 100% mesothelin expression included 12 cases of squamous cell carcinoma, 1 uncategorized case of thymic carcinoma and 1 case of B3 thymoma. T: thymoma; TC: thymic carcinoma; TNET: thymic neuroendocrine tumors.